BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 23280131)

  • 1. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.
    la Marca G; Canessa C; Giocaliere E; Romano F; Duse M; Malvagia S; Lippi F; Funghini S; Bianchi L; Della Bona ML; Valleriani C; Ombrone D; Moriondo M; Villanelli F; Speckmann C; Adams S; Gaspar BH; Hershfield M; Santisteban I; Fairbanks L; Ragusa G; Resti M; de Martino M; Guerrini R; Azzari C
    J Allergy Clin Immunol; 2013 Jun; 131(6):1604-10. PubMed ID: 23280131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry.
    la Marca G; Giocaliere E; Malvagia S; Funghini S; Ombrone D; Della Bona ML; Canessa C; Lippi F; Romano F; Guerrini R; Resti M; Azzari C
    J Pharm Biomed Anal; 2014 Jan; 88():201-6. PubMed ID: 24076575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
    la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
    J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome.
    Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ
    J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry.
    Azzari C; la Marca G; Resti M
    J Allergy Clin Immunol; 2011 Jun; 127(6):1394-9. PubMed ID: 21624616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a routine newborn screening protocol for severe combined immunodeficiency.
    Baker MW; Grossman WJ; Laessig RH; Hoffman GL; Brokopp CD; Kurtycz DF; Cogley MF; Litsheim TJ; Katcher ML; Routes JM
    J Allergy Clin Immunol; 2009 Sep; 124(3):522-7. PubMed ID: 19482345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID).
    Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H
    Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.
    Somech R; Lev A; Simon AJ; Korn D; Garty BZ; Amariglio N; Rechavi G; Almashanu S; Zlotogora J; Etzioni A
    Isr Med Assoc J; 2013 Aug; 15(8):404-9. PubMed ID: 24079059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency.
    Hartog N; Hershfield M; Michniacki T; Moloney S; Holsworth A; Hurden I; Fredrickson M; Kleyn M; Walkovich K; Secord E
    Ann Allergy Asthma Immunol; 2022 Dec; 129(6):776-783.e2. PubMed ID: 35914665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of population-based newborn screening for severe combined immunodeficiency.
    Chan K; Puck JM
    J Allergy Clin Immunol; 2005 Feb; 115(2):391-8. PubMed ID: 15696101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Droplet Digital PCR Method for Severe Combined Immunodeficiency Newborn Screening.
    Vidal-Folch N; Milosevic D; Majumdar R; Gavrilov D; Matern D; Raymond K; Rinaldo P; Tortorelli S; Abraham RS; Oglesbee D
    J Mol Diagn; 2017 Sep; 19(5):755-765. PubMed ID: 28826609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
    Otsu M; Yamada M; Nakajima S; Kida M; Maeyama Y; Hatano N; Toita N; Takezaki S; Okura Y; Kobayashi R; Matsumoto Y; Tatsuzawa O; Tsuchida F; Kato S; Kitagawa M; Mineno J; Hershfield MS; Bali P; Candotti F; Onodera M; Kawamura N; Sakiyama Y; Ariga T
    J Clin Immunol; 2015 May; 35(4):384-98. PubMed ID: 25875699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-Onset ADA1 (ADA) Deficiency Not Detected by TREC Screen.
    Kahwash BM; Yonkof JR; Abraham RS; Mustillo PJ; Abu-Arja R; Rangarajan HG; Scherzer R
    Pediatrics; 2021 Jun; 147(6):. PubMed ID: 33975924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.
    Nikolajeva O; Worth A; Hague R; Martinez-Alier N; Smart J; Adams S; Davies EG; Gaspar HB
    J Clin Immunol; 2015 May; 35(4):366-72. PubMed ID: 25875700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining combined immunodeficiency.
    Roifman CM; Somech R; Kavadas F; Pires L; Nahum A; Dalal I; Grunebaum E
    J Allergy Clin Immunol; 2012 Jul; 130(1):177-83. PubMed ID: 22664165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The successful inclusion of ADA SCID in Tuscany expanded newborn screening program.
    Malvagia S; Funghini S; Della Bona M; Ombrone D; Mura M; Damiano R; Ricci S; Cortimiglia M; Azzari C; la Marca G
    Clin Chem Lab Med; 2021 Sep; 59(10):e401-e404. PubMed ID: 33951760
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of severe combined immunodeficiency by T-cell receptor excision circles quantification using neonatal guthrie cards.
    Morinishi Y; Imai K; Nakagawa N; Sato H; Horiuchi K; Ohtsuka Y; Kaneda Y; Taga T; Hisakawa H; Miyaji R; Endo M; Oh-Ishi T; Kamachi Y; Akahane K; Kobayashi C; Tsuchida M; Morio T; Sasahara Y; Kumaki S; Ishigaki K; Yoshida M; Urabe T; Kobayashi N; Okimoto Y; Reichenbach J; Hashii Y; Tsuji Y; Kogawa K; Yamaguchi S; Kanegane H; Miyawaki T; Yamada M; Ariga T; Nonoyama S
    J Pediatr; 2009 Dec; 155(6):829-33. PubMed ID: 19628217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
    Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
    J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
    Richards S; Pitt J; Choo S
    J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase deficiency.
    Hirschhorn R
    Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.